Bilirubin: Bilitool Bili Tool
Bilirubin: Bilitool Bili Tool
Download on App Store

This page is not an official page of the app or its developer, but an independent editorial publication created for informational and commentary purposes. Unless expressly stated otherwise, neither the app nor its developer is affiliated with, endorsed by, sponsored by, authorized by, or otherwise officially connected with MWM, Apple, Google Play, the app publisher, or the app's developer, and nothing on this page implies that the app was developed using MWM's services. Any trademarks, logos, screenshots, and other content remain the property of their respective owners.

Logo of Bilirubin: Bilitool Bili Tool
Download on App Store

Bilirubin: Bilitool Bili Tool

Instantly access 2022 and 2004 AAP recommendations on one offline screen. Built by a physician to provide pediatric professionals with accurate, bedside treatment decisions in seconds.

Key Figures

Downloads

57K+

User Rating

4.8/5

Total Ratings

0

Publisher

Jeffrey Fulton

Category

Medical

Locales

1

Latest Version

3.2

Size

6.3 MB

First Released

Mar 27, 2020
Features

Precision Clinical Support at Your Fingertips

Streamline newborn jaundice management with instant AAP guideline calculations, visual nomograms, and offline reliability—designed by physicians for clinical excellence.

Latest AAP Guidelines

Toggle seamlessly between 2022 and 2004 AAP standards to ensure your management plans remain compliant, evidence-based, and hospital-policy aligned.

Automated Clinical Math

Eliminate manual calculation errors by determining age in hours directly from birth and lab times for immediate, error-free treatment recommendations.

FAQ

Frequently Asked Questions

Everything you need to know about Bilirubin: Bilitool Bili Tool

What is the Bilirubin: Bilitool Bili Tool app?

Bilirubin: Bilitool Bili Tool is an app based on the 2022 American Academy of Pediatrics (AAP) guidelines for managing hyperbilirubinemia in newborns. It was designed by family physician Dr. Émilie Coudière, MD.

Does Bilirubin: Bilitool Bili Tool include the latest AAP guidelines?

Yes, Bilirubin: Bilitool Bili Tool includes the 2022 American Academy of Pediatrics (AAP) guidelines. The app also provides access to the previous 2004 guidelines via an in-app toggle.

What key features does the Bilirubin: Bilitool Bili Tool app provide?

Bilirubin: Bilitool Bili Tool offers management recommendations, guideline nomogram visualizations, patient age input options, support for US and SI units, risk factor lists, and direct links to guideline sections.

The following screenshots and description are sourced directly from the app's official store listing and are the property of the app developer.

App Store

Screenshots

Bilirubin: Bilitool Bili Tool - Bilitool app screen for calculating newborn bilirubin levels and phototherapy recommendations based on AAP guidelines

Bilitool app screen for calculating newborn bilirubin levels and phototherapy recommendations based on AAP guidelines

Bilirubin: Bilitool Bili Tool - Bilitool mobile app interface showing bilirubin treatment recommendations and AAP guidelines graph.

Bilitool mobile app interface showing bilirubin treatment recommendations and AAP guidelines graph.

Bilirubin: Bilitool Bili Tool - Bilitool app interface showing newborn jaundice management recommendations and follow-up advice based on AAP guidelines.

Bilitool app interface showing newborn jaundice management recommendations and follow-up advice based on AAP guidelines.

Bilirubin: Bilitool Bili Tool - Bilitool app interface for entering postnatal age using birth and blood sampling times.

Bilitool app interface for entering postnatal age using birth and blood sampling times.

Bilirubin: Bilitool Bili Tool - Interface of the Bilirubin Bilitool app showing selection between US and SI units.

Interface of the Bilirubin Bilitool app showing selection between US and SI units.

Bilirubin: Bilitool Bili Tool - Bilitool app interface showing neonatal jaundice risk factors and AAP guidelines recommendations

Bilitool app interface showing neonatal jaundice risk factors and AAP guidelines recommendations

Bilirubin: Bilitool Bili Tool - Interface of the Bilirubin app showing direct links to AAP medical guidelines for jaundice management

Interface of the Bilirubin app showing direct links to AAP medical guidelines for jaundice management

Bilirubin: Bilitool Bili Tool - Bilitool medical app interface in dark mode showing bilirubin assessment tools

Bilitool medical app interface in dark mode showing bilirubin assessment tools

Description

*** NEW! 2022 and 2004 AAP Guidelines now included! *** Offline Bilitool in one screen. Based on the 2022 American Academy of Pediatrics (AAP) "Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation" guidelines. Previous 2004 guidelines also available via an in-app toggle. Designed and developed by family physician Dr. Émilie Coudière, MD. FEATURES • Management and follow-up recommendations according to patient's age, bilirubin level, gestational age at birth, risk factors. • Guideline nomograms provide visualization of results. • Patient's age can be entered directly or from birth and lab sample times. • Support for US and SI units (mg/dL and μmol/L). • List of hyperbilirubinemia and neurotoxicity risk factors for quick reference. • Direct links to specific sections of the guidelines for quick reference. * Terms of use are available at https://jeffreyfulton.ca/bilirubin/terms

Download

Download on App Store

This page is not an official page of the app or its developer, but an independent editorial publication created for informational and commentary purposes. Unless expressly stated otherwise, neither the app nor its developer is affiliated with, endorsed by, sponsored by, authorized by, or otherwise officially connected with MWM, Apple, Google Play, the app publisher, or the app's developer, and nothing on this page implies that the app was developed using MWM's services. Any trademarks, logos, screenshots, and other content remain the property of their respective owners.